"How much does metastatic colon cancer treatment cost?"

"Total Stage IV treatment commonly runs $250,000–$500,000+ over a course of care. With insurance, your personal cost is capped at your annual out-of-pocket maximum, typically $7,000–$16,000 per year."

"Does insurance cover Stage IV colon cancer treatment?"

"Yes. All major insurance covers metastatic cancer treatment as medically necessary. You'll pay your out-of-pocket maximum each treatment year, but the rest is covered."

"What's the most expensive part of metastatic colon cancer treatment?"

"Targeted therapy and immunotherapy drugs are the costliest, often $100,000–$300,000+ per year before insurance. Liver or lung metastasis surgery and ongoing chemo also add major charges."

Metastatic Colon Cancer Treatment Cost: Stage IV Therapy and Total Care Prices

📋 Data from Medicare fee schedules & FAIR Health ✓ Reviewed by board-certified gastroenterologist 🔄 Updated May 2026

A Stage IV diagnosis hits like a wall. The cancer has spread beyond the colon — often to the liver or lungs — and treatment becomes a long-term, multi-pronged effort rather than a single surgery. The costs are large, but so is the progress: survival for metastatic colorectal cancer has improved substantially over the past two decades, the NCI notes, thanks to better drugs and surgical techniques.

If you’re staring down these bills, here’s the honest, complete picture of what Stage IV treatment costs and what insurance actually protects you from.

Metastatic Treatment Costs

Treatment Component	Typical Total Charge	Your Cost (Insured)
Systemic chemotherapy (FOLFOX/FOLFIRI, per year)	$50,000 – $150,000	OOP max each year
Targeted therapy (bevacizumab, cetuximab, per year)	$80,000 – $200,000	OOP max each year
Immunotherapy (per year)	$100,000 – $300,000	OOP max each year
Liver metastasis resection	$60,000 – $150,000	$6,000 – $18,000
Hepatic artery infusion / ablation	$30,000 – $100,000	Varies
Total course of care (multi-year)	$250,000 – $500,000+	OOP max × years

The total course numbers are staggering, but the key thing to hold onto is that your personal cost is capped each year by your out-of-pocket maximum — not the full list charge.

The Drugs Are the Big Driver

Key Takeaway

The most expensive part of Stage IV treatment is the medications. Targeted therapy and immunotherapy can run $100,000–$300,000+ per year before insurance. The good news: with commercial insurance you pay only up to your annual out-of-pocket maximum (typically $7,000–$16,000 in-network for 2025 plans), and drug manufacturers run copay assistance and patient foundations that can cover much of even that. No one with insurance should pay the full sticker price for these drugs.

The drug components are detailed in our colorectal cancer targeted therapy cost and colorectal cancer immunotherapy cost guides, while the chemo backbone follows the structure in colon cancer chemotherapy cost.

Surgery Still Has a Role

For some Stage IV patients, surgery isn’t off the table. If metastases are limited to the liver or lungs, removing them can extend survival significantly — sometimes for years. Those operations mirror the costs in our colon cancer surgery cost guide, with the added expense of liver or lung resection.

How It Compares Across Stages

Stage IV is by far the most expensive stage to treat, which is the entire argument for early detection. The cost gap between catching cancer at Stage I versus Stage IV is enormous, as laid out in our colon cancer treatment cost by stage guide. A routine colonoscopy is a tiny fraction of what advanced treatment runs.

Insurance Coverage

Metastatic cancer treatment is covered by all major insurance:

Commercial plans: Annual out-of-pocket maximum caps your yearly cost. Expect to hit it every treatment year.
Medicare: Part B for infusions, Part D for oral drugs, Part A for hospitalizations. Medigap helps with cost-sharing; the 2025 Part D out-of-pocket cap ($2,000) is a major help for oral oncology drugs.
Medicaid: Covers treatment with minimal out-of-pocket cost.

Ongoing treatment means hitting your out-of-pocket maximum year after year, which adds up even when each year is capped. Get connected with your cancer center’s financial navigator immediately. Manufacturer copay cards, the new $2,000 Medicare Part D cap, and nonprofit foundations can dramatically reduce your real annual burden — but you have to apply.

The Bottom Line

Metastatic colon cancer treatment can exceed $250,000–$500,000 over a full course, driven mostly by targeted and immunotherapy drugs. But with insurance, your personal cost is capped at your annual out-of-pocket maximum, and assistance programs can shave that down further. The treatments keep improving, and so does survival — making it more worthwhile than ever to navigate the financial side with help from a dedicated cancer financial navigator.

Disclaimer: Cost figures are estimates for US patients based on 2025–2026 published fee schedules, Medicare data, and FAIR Health benchmarks. Actual costs vary by location, provider, plan, and procedure complexity. This site does not provide medical advice. Always verify costs with your provider before scheduling.